» Articles » PMID: 39340112

Differences in PCV13 Recommendation Practices Between Pediatric Care Providers and Primary Care Providers in China: A Cross-Sectional Survey of Behavior and Social Drivers

Overview
Date 2024 Sep 28
PMID 39340112
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the recommendation behaviors and influencing factors for the 13-valent Pneumococcal Conjugate Vaccine (PCV13) among 3579 Chinese healthcare workers (HCWs), including 1775 pediatric care providers (Peds-PCPs) and 1804 primary care providers (PCPs). Data were collected from May to July 2023 through a national cross-sectional survey using a structured questionnaire, distributed across hospitals providing pediatric services in five provincial-level administrative divisions. The sociodemographic data, vaccine knowledge, and recommendation practices were analyzed using Pearson's chi-square test, Wilcoxson rank-sum test, and multivariate logistic regression. Results show that while PCPs are more likely to recommend PCV13, vaccine hesitancy persists among Peds-PCPs. Logistic regression revealed that higher influenza vaccination intention, salary, vaccine consultation frequency, familiarity with immunization, work ethic, and flexible schedules positively impacted HCWs' recommendation behavior. Factors influencing Peds-PCPs' recommendations include vaccine training (OR: 1.470, CI: 1.049-2.509), safety recognition (OR: 1.986, CI: 1.163-3.391), concern over rejection (OR = 1.274, CI: 1.076-1.508) and vaccine cost (OR = 1.203, CI: 1.023-1.414). For PCPs, influencing factors were the perceived susceptibility of children to pneumonia (OR = 2.185, CI: 1.074-4.445), acceptance of herd immunity (OR: 1.717, CI: 1.101-2.677), and belief that parents with better family conditions are more likely to accept vaccine recommendations (OR = 1.229, CI: 1.024-1.477). This survey underscores the need for tailored interventions to address differing perceptions and enhance confidence in the safety and efficacy of vaccines among HCWs, particularly Peds-PCPs.

References
1.
Liu L, Zhang Z, Zhang X, Xu C, Song Y, Li L . Coverage of 13-Valent Pneumococcal Conjugate Vaccine Among Children 0-15 Months of Age - 9 Provinces, China, 2019-2021. China CDC Wkly. 2023; 5(17):379-384. PMC: 10184383. DOI: 10.46234/ccdcw2023.072. View

2.
Kaur M, Coppeta L, Olesen O . Vaccine Hesitancy among Healthcare Workers in Europe: A Systematic Review. Vaccines (Basel). 2023; 11(11). PMC: 10675787. DOI: 10.3390/vaccines11111657. View

3.
OBrien K, Wolfson L, Watt J, Henkle E, Deloria-Knoll M, McCall N . Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009; 374(9693):893-902. DOI: 10.1016/S0140-6736(09)61204-6. View

4.
Davies B, Olivier J, Amponsah-Dacosta E . Health Systems Determinants of Delivery and Uptake of Maternal Vaccines in Low- and Middle-Income Countries: A Qualitative Systematic Review. Vaccines (Basel). 2023; 11(4). PMC: 10144938. DOI: 10.3390/vaccines11040869. View

5.
Eller N, Henrikson N, Opel D . Vaccine Information Sources and Parental Trust in Their Child's Health Care Provider. Health Educ Behav. 2019; 46(3):445-453. PMC: 7872219. DOI: 10.1177/1090198118819716. View